# A Study to Examine Past Estimated Glomerular Filtration Rate (eGFR) Slope as a Risk Marker for Rapid Kidney Function Decline in People With Chronic Kidney Disease

> **NCT04881448** · PHASE2 · TERMINATED · sponsor: **Boehringer Ingelheim** · enrollment: 223 (actual)

## Conditions studied

- Chronic Kidney Disease

## Interventions

- **DIAGNOSTIC_TEST:** collection of serum/capillary creatinine values

## Key facts

- **NCT ID:** NCT04881448
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-09-16
- **Primary completion:** 2022-07-15
- **Final completion:** 2022-07-15
- **Target enrollment:** 223 (ACTUAL)
- **Why stopped:** Recruitment challenges
- **Last updated:** 2023-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04881448

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04881448, "A Study to Examine Past Estimated Glomerular Filtration Rate (eGFR) Slope as a Risk Marker for Rapid Kidney Function Decline in People With Chronic Kidney Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04881448. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*